UNICA IRIS Institutional Research Information System

FARCI, PATRIZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 59.327
NA - Nord America 4.193
AS - Asia 447
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
AF - Africa 2
SA - Sud America 1
Totale 63.978
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 58.207
US - Stati Uniti d'America 4.182
UA - Ucraina 450
CN - Cina 383
SE - Svezia 288
FI - Finlandia 107
GB - Regno Unito 106
DE - Germania 102
FR - Francia 29
SG - Singapore 20
IN - India 16
IR - Iran 13
CA - Canada 11
RU - Federazione Russa 10
VN - Vietnam 8
NL - Olanda 7
EU - Europa 4
IE - Irlanda 3
PK - Pakistan 3
RO - Romania 3
AT - Austria 2
AU - Australia 2
CH - Svizzera 2
DK - Danimarca 2
ES - Italia 2
GR - Grecia 2
IQ - Iraq 2
MU - Mauritius 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
BE - Belgio 1
BR - Brasile 1
CZ - Repubblica Ceca 1
GE - Georgia 1
JP - Giappone 1
LU - Lussemburgo 1
Totale 63.978
Salva come PNG Salva come JPEG
Città #
Cagliari 58.016
Fairfield 586
Chandler 481
Woodbridge 450
Houston 362
Ashburn 259
Ann Arbor 249
Jacksonville 243
Seattle 234
Wilmington 229
Cambridge 200
Nyköping 180
Dearborn 123
Boardman 106
Beijing 73
Nanjing 70
Boston 65
Helsinki 36
Shanghai 34
Milan 32
San Diego 32
Shenyang 26
Guangzhou 24
Hebei 22
Nanchang 22
Verona 20
Changsha 19
Redwood City 18
Sassari 17
Jiaxing 16
Pune 14
Falls Church 13
Norwalk 12
Tianjin 11
Hefei 10
London 10
Mountain View 10
Orange 10
Auburn Hills 9
Guasila 9
Los Angeles 9
Ningbo 9
Renton 9
Dong Ket 8
Redmond 7
Zhengzhou 7
Jinan 6
Kunming 6
New York 6
Toronto 6
Washington 6
Chicago 5
Atlanta 4
Walnut 4
Augusta 3
Catania 3
Edinburgh 3
Hangzhou 3
Kilburn 3
Taizhou 3
Tehran 3
Ussana 3
Amsterdam 2
Auckland 2
Bhubaneswar 2
Cassano d'Adda 2
Cedar Knolls 2
Chengdu 2
Chongqing 2
Columbus 2
Copenhagen 2
Detroit 2
Dublin 2
Fuzhou 2
Islington 2
Lausanne 2
Madrid 2
Mashhad 2
Oslo 2
Oxford 2
Phoenix 2
Rockville 2
Saint Petersburg 2
San Mateo 2
Thessaloniki 2
Valenzano 2
Vienna 2
Aachen 1
Bethesda 1
Borris 1
Borås 1
Brasília 1
Brussels 1
Chaoyang 1
Chiswick 1
Esslingen am Neckar 1
Gonnosfanadiga 1
Groningen 1
Gunzenhausen 1
Hamburg 1
Totale 62.531
Salva come PNG Salva come JPEG
Nome #
Liver Regeneration Signature in Hepatitis B Virus (HBV)-Associated Acute Liver Failure Identified by Gene Expression Profiling 2.792
Neutralizing antibodies to hepatitis C virus in perinatally infected children followed up prospectively 2.569
Profibrogenic chemokines and viral evolution predict rapid progression of hepatitis C to cirrhosis 2.488
Evolution of hepatitis C viral quasispecies and hepatic injury in perinatally infected children followed prospectively 2.397
Viral expression and molecular profiling in liver tissue versus microdissected hepatocytes in hepatitis B virus - associated hepatocellular carcinoma. 2.377
Identification of microRNAs specifically expressed in hepatitis C virus-associated hepatocellular carcinoma 2.359
Association of chronic hepatitis C with recurrent brief depression 2.252
Integrated ordination of miRNA and mRNA expression profiles 2.205
Diminished viral replication and compartmentalization of hepatitis C virus in hepatocellular carcinoma tissue 2.037
Natural history of hepatitis C in thalassemia major: a long-term prospective study 1.954
null 1.610
Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B 1.511
Role of humoral immunity against hepatitis B virus core antigen in the pathogenesis of acute liver failure 1.506
Epidemiology of infection with HIV-1 in Sardinia: a multicentre prospective study 1.478
Infection with hepatitis C virus depends on TACSTD2, a regulator of claudin-1 and occludin highly downregulated in hepatocellular carcinoma 1.477
null 1.445
Hepatic stem cells and transforming growth factor beta in hepatocellular carcinoma 1.363
Molecular signature and mechanisms of hepatitis D virus–associated hepatocellular carcinoma 1.333
Response to peginterferon alfa-2a (40KD) in HBeAg-negative CHB: On-treatment kinetics of HBsAg serum levels vary by HBV genotype 1.323
Clinical Features of Hepatitis D 1.294
Specificity of an anti-capsid antibody associated with Hepatitis B Virus-related acute liver failure 1.283
New Insights into the HCV Quasispecies and Compartmentalization 1.260
Sustained response of hepatitis B e antigen-negative patients 3 years after treatment with peginterferon alpha-2a. 1.170
Experimental transmission of hepatitis C virus associated fulminant hepatitis to a chimpanzee 1.109
Increased survival and reversion of iron-induced cardiac disease in patients with thalassemia major receiving intensive combined chelation therapy as compared to desferoxamine alone. 1.086
Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B. 1.026
The use of molecular assays in the management of viral hepatitis 811
Comparing the safety, tolerability and quality of life in patients with chronic hepatitis B vs chronic hepatitis C treated with peginterferon alpha-2a. 759
Association of chronic hepatitis C with major depressive disorders: irrespective of interferon-alpha therapy 615
Treatment of chronic hepatitis C in patients with glucose-6-phosphate dehydrogenase deficiency: is ribavirin harmful? 542
Viral escape and the failure of cellular immune responses 537
Treatment of chronic hepatitis D 520
Treatment of patients with Chronic Hepatitis Delta 515
Viral and metabolic factors influencing alanine aminotransferase activity in patients with chronic hepatitis C 503
Predicting response to peginterferon alfa-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B 491
Treatment of chronic hepatitis D: New advances, old challenges 487
Chronic viral hepatitis D 484
Severe autoimmune hemolytic anemia in a patient with chronic hepatitis C during treatment with peginterferon alfa-2a and ribavirin 445
In Vivo study of the HC-TN Strain of Hepatitis C Virus Recovered from a Case of Fulminant Hepatitis: RNA Transcripts of a Molecular Clone (pHC-TN) are Infectious in Chimpanzees but not in Huh7.5 cells 442
The economics of treating chronic hepatitis C patients with peginterferon alpha-2a (40 kDa) plus ribavirin presenting with persistently normal aminotransferase 438
Natural history and experimental models of hepatitis C 430
Hepatitis D (Delta) Virus 422
Immune Response to Hepatitis C Virus 415
Longitudinal analysis of serum chemokine levels in the course of HIV-1 infection 410
null 399
Implicazioni biologiche e cliniche della quasispecie virale 398
Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B 394
L’epatite delta 387
The quasispecies of hepatitis C virus and host immune response 375
A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures 370
Lack of protective immunity against reinfection with hepatitis C virus 361
Clinical relevance of hepatitis C virus genetic variability 359
Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1. 346
Hepatitis C virus associated fulminant hepatic failure 343
Long term study of hepatitis C virus replication in non-A non-B hepatitis 327
Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcome 323
The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies 309
Evaluation of antibodies to hepatitis C virus in a long-term prospective study of post-transfusion hepatitis among thalassemic children: comparison between first- and second- generation assay 306
Acute viral hepatitis in Saudi Arabia: seroepidemiological analysis, risk factors, clinical manifestations, and evidence for a sixth hepatitis agent. 304
Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassemic children 303
Virological mechanisms of viral persistence, resolution and reinfection 303
Milestones in Liver Disease 300
The role of pre-core hepatitis B virus mutants on the long-term outcome of chronic hepatitis B virus hepatitis. A longitudinal study. 300
Prevention of hepatitis C virus infection in chimpanzee by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein 295
Markers of hepatitis C virus infection in Sardinian blood donors: relationship with alanine aminotransferase levels. 292
Delta hepatitis: an update 291
Hepatitis C virus. The importance of viral heterogeneity 290
Hepatitis type C after orthotopic liver transplantation: reinfection and disease recurrence. 284
Peginterferon alfa-2a (40 KD) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels 284
La ricerca biomedica 266
Prevention of hepatitis C virus infection in chimpanzee after antibody-mediated in vitro neutralization 265
Immunity elicited by hepatitis C virus. 262
HCV diversity, dynamics and turnover 255
HCV-associated lymphomas 251
Molecular basis of viral resistance to interferon in chronic hepatitis C 245
Clinical significance of hepatitis C virus genotypes and quasispecies 231
Long-term benefit of interferon alpha therapy of chronic hepatitis D: regression of advanced hepatic fibrosis 64
Treatment of chronic hepatitis D with interferon alfa-2a 16
Totale 64.068
Salva come PNG Salva come JPEG
Categoria #
all - tutte 80.194
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.194
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019552 0 0 0 0 0 0 0 0 0 0 267 285
2019/202013.828 1.004 474 78 244 5.339 3.482 1.680 468 249 203 253 354
2020/202116.044 492 440 492 5.368 3.958 1.346 1.195 889 249 744 514 357
2021/20224.003 303 418 235 246 362 341 282 230 261 293 501 531
2022/20235.574 620 696 748 416 541 495 145 860 333 227 240 253
2023/20244.015 397 263 272 453 462 667 534 317 221 398 31 0
Totale 64.068